Kevzara (sarilumab)

pCPA File Number: 20973

Negotiation Status:

Concluded without agreement

Indication(s):

Rheumatoid Arthritis

Sponsor/Manufacturer:

Sanofi-Aventis Canada Inc.

CDA-AMC Project Number:

SR0503-000

pCPA Engagement Letter Issued:

2017-07-28

Negotiation Process Concluded:

2017-10-26